Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: cervical cancer application
Loading...
Authors
Guani, Benedetta
Gaillard, Thomas
Teo-Fortin, Ly-Ann
Balaya, Vincent
Feki, Anis
Paoletti, Xavier
Mathevet, Patrice
Plante, Marie
Lecuru, Fabrice
Issue Date
2022-08-12
Type
Article
Language
en_US
Keywords
Cervical Cancer , Lymph Nodal Status , Early-Stage Cervical Cancer , Cervical Cancer Web Application , Gynecological Cancers
Alternative Title
Abstract
Introduction:
Lymph node status is a major prognostic factor in early-stage cervical cancer. Predicting the risk of lymph node metastasis is essential for optimal therapeutic management. The aim of the study was to develop a web-based application to predict the risk of lymph node metastasis in patients with early-stage (IA1 with positive lymph vascular space invasion, IA2 and IB1) cervical cancer.
Materials and methods:
We performed a secondary analysis of data from two prospective multicenter trials, Senticol 1 and 2 pooled together in the training dataset. The histological risk factors were included in a multivariate logistic regression model in order to determine the most suitable prediction model. An internal validation of the chosen prediction model was then carried out by a cross validation of the ‘leave one out cross validation’ type. The prediction model was implemented in an interactive online application of the ‘Shinyapp’ type. Finally, an external validation was performed with a retrospective cohort from L’Hôtel-Dieu de Québec in Canada.
Results:
Three hundred twenty-one patients participating in Senticol 1 and 2 were included in our training analysis. Among these patients, 280 did not present lymph node invasion (87.2%), 13 presented isolated tumor cells (4%), 11 presented micrometastases (3.4%) and 17 macrometastases (5.3%). Tumor size, presence of lymph-vascular space invasion and stromal invasion were included in the prediction model. The Receiver Operating Characteristic (ROC) Curve from this model had an area under the curve (AUC) of 0.79 (95% CI [0.69– 0.90]). The AUC from the cross validation was 0.65. The external validation on the Canadian cohort confirmed a good discrimination of the model with an AUC of 0.83.
Discussion:
This is the first study of a prediction score for lymph node involvement in early-stage cervical cancer that includes internal and external validation. The web application is a simple, practical, and modern method of using this prediction score to assist in clinical management.
Description
Citation
Guani, B., Gaillard, T., Teo-Fortin, L. A., Balaya, V., Feki, A., Paoletti, X., Mathevet, P., Plante, M., & Lecuru, F. (2022). Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application. Frontiers in oncology, 12, 935628. https://doi.org/10.3389/fonc.2022.935628
Publisher
Frontiers in Oncology